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Abstract 
Background: The urinary proteome of patients undergoing cardiopulmonary bypass (CPB) may provide important 
insights into systemic and renal changes associated with the procedure. Such information may ultimately provide 
a basis to differentiate changes or properties associated with the development of acute kidney injury. While mass 
spectrometry (MS) analysis offers the potential for in-depth compositional analysis it is often limited in coverage and 
relative quantitation capacity. The aim of this study was to develop a process flow for the preparation and comparison 
of the intraoperative urinary proteome.
Methods: Urines were collected from patients at the start of CPB and 1-h into CPB. Pooled samples (n = 5) from each 
time point were processed using a modified Filter Assisted Sample Preparation protocol. The resulting peptides were 
analyzed by 2D-LC–MS/MS and by 1D-LC–MS/MS SWATH (Sequential Window acquisition of All Theoretical fragment 
ion spectra).
Results: The 2D-LC–MS/MS analysis identified 1324 proteins in the two pools, of which 744 were quantifiable. The 
SWATH approach provided quantitation for 730 proteins, 552 of which overlapped with the common population from 
the 2D-IDA results. Intensity correlation filtering between the two methods gave 475 proteins for biological interpre-
tation. Proteins displaying greater than threefold changes (>log2 1.59) at 1-hour CPB relative to the initiation of CPB 
(26 down-regulated and 22 up-regulated) were selected for further analysis. Up-regulated proteins were enriched 
in GO terms related to humoral immune response, predominantly innate immunity (C4b, lactotransferrin, protein 
S100-A8, cathelicidin, myeloperoxidase) and extracellular matrix reorganization (e.g. MMP-9).
Conclusions: This study describes a scheme for processing urine from patients undergoing CPB for mass spectrome-
try-based analysis. The introduction of SWATH into the workflow offers a sample and instrument sparing approach to 
obtaining consistent in-depth sample analysis. The design of the methodology is such that it can be readily applied 
to large numbers of clinical samples with the potential for automation. The results also suggest that activation of the 
innate immune responses occur during cardiac bypass surgery.
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Background
Urine proteomic analysis is a powerful tool that may 
provide insights into protein changes that are predic-
tive of disease development and to define underlying 
pathophysiologic processes. Urine provides a non-
invasive, rich source of proteins that are potentially 
informative of systemic and renal processes. Indeed 
while there are unique aspects to the urine proteome, 
it has been shown to have approximately 61 % overlap 
with both the kidney and plasma proteomes [1]. These 
considerations have been the rationale for a number of 
proteomic studies of urinary proteins [2–5]. However, 
urine proteomic analysis is complicated by protein con-
centration variability, the presence of interfering salts, 
metabolites and other substances [6]. These considera-
tions often require significant sample processing which 
can impact the reproducibility of quantitative analysis 
of urine [7].
Different urine proteomics approaches have been 
applied to clinical scenarios in the intensive care unit [5, 
8], renal transplants [9, 10], and pre/post-operative car-
diac surgery [2]. However, proteomic evaluation of intra-
operative urines is particularly challenging because of 
the presence of unique inhibitory materials that interfere 
with chromatography. Only targeted SELDI TOF–MS 
analysis has been successfully applied to intra-operative 
cardiac surgery urine samples [3, 11, 12], however this 
approach offers extremely limited proteome coverage 
and does not provide specific protein identification.
Shotgun proteomics on complex biological samples 
using in-depth 2D-LC–MS/MS analysis provides maxi-
mum proteome coverage and protein identification. 
However, the stochastic nature of DDA/IDA peptide 
selection for analysis often results in variable identifi-
cation coverage between analyses [1, 13, 14]. Sequen-
tial Window acquisition of All Theoretical fragment ion 
spectra Mass-Spectrometry (SWATH-MS) has been pro-
posed as an alternative approach [15]. SWATH-MS offers 
accurate and reproducible protein quantification from 
complex samples using data-independent acquisition. A 
significant advantage of SWATH analysis is that it reports 
the relative abundance of selected proteins in different 
samples. SWATH-MS also provides a permanent digital 
file representing the continuous MS-measurable pro-
teome of a sample that can subsequently be re-analyzed 
as new approaches and insights become available [16].
This study describes a workflow for the processing and 
analysis of urines from adult patients undergoing cardiac 
bypass surgery. A comparison of DDA/IDA and SWATH-
based analysis is provided suggesting that the latter may 




The study protocol was approved by the Health Research 
Ethics Board, University of Manitoba and all patients 
provided informed consent. Patients with stable renal 
function (n = 5) were selected for analysis from a larger 
prospective observational cohort of adult cardiac sur-
gery patients using the following criteria: baseline esti-
mated glomerular filtration rate (eGFR) ≥60 mL/min and 
post-operative serum creatinine rise <10  % from base-
line. Serial urine samples were collected at the initiation 
of CPB and after 1-h on CPB. Urines were spun at 870 g 
for 6 min, and the supernatants stored at −80 °C for fur-
ther analysis. The baseline clinical characteristics of the 
patient cohort are described in Table 1.
Sample preparation for mass‑spectrometry analysis
Total urine protein was quantified using a total Protein 
Kit, Micro Pyrogallol Red Method (Sigma, USA). A pool of 
urines from 5 patients (40 µg protein/patient) was prepared 
for each time point. The pooled samples were processed 
using a modified FASP protocol [17]. Pooled urines were 
treated for 5 min with 0.1 M DTT at 100  °C. The cooled 
samples were brought to 8  M urea, 100  mM Tris pH 8.0 
Table 1 Baseline patient characteristics
Values expressed as median (interquartile range) or N (percent). Continuous 
variables compared using Mann–Whitney test, categorical variables compared 
using Chi-square or Fisher’s Exact Test
Variable Patients (n = 5)
Age (years) 75 (73–77)
Male 3 (60 %)
eGFR (mL/min/1.72 m2) 72.5 (69.2–76.5)
Baseline creatinine (mg/dL) 94 (69–97)
THAKAR Score 2 (1–2)
Diabetes mellitus 1 (20 %)
Chronic obstructive pulmonary disease 1 (20 %)
Hospitalized congestive heart failure 1 (20 %)
Previous myocardial infarction 2 (40 %)
Previous CABG 0 (0 %)
Peripheral arterial disease 1 (20 %)
Amputation or peripheral arterial disease bypass 0 (0 %)
Previous cerebrovascular accident 0 (0 %)
Previous transient ischemic attack 1 (20 %)
Type of surgery (isolated CABG) 3 (60 %)
Pump time (min) 68 (64–95)
Cross-clamp time (min) 54 (36–78)
Operating room duration (min) 254 (250–305)
European system for cardiac operation risk evaluation 
EuroSCORE II
1.5 % (1.0–2.4 %)
Intraoperative urine output (mL) 1180 (800–1350)
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and diluted with an equal volume of the same solution. The 
samples were transferred to the indicated Amicon MWCO 
ultra-15 centrifugal filter (Millipore) (i.e. 3, 10 or 30  kDa 
cut-off) and centrifuged at 4000×g for 15 min. The reten-
tate was then diluted to 15 ml with 8 M urea, 100 mM Tris 
pH 8.0 and centrifuged for 30–50 min at 4000×g to remove 
excess DTT. This was repeated once after which 2  ml of 
50 mM iodoacetamide was added to the sample and incu-
bated in the dark for 15 min. The sample was centrifuged 
for 15 min at 4000×g and 2 ml of 20 mM DTT was added 
to react with residual iodoacetamide. The sample was cen-
trifuged for 15  min at 4000×g, after which the retentate 
was brought to 500  μl with 50  mM ammonium bicarbo-
nate. Trypsin was added at 1:50 ratio based on the starting 
protein amount and the sample was incubated overnight 
at 28 °C with shaking. The digest was brought to 500 mM 
NaCl and gently mixed. The samples were centrifuged for 
15  min at 4000×g. The MWCO filter was washed with 
200 μl of water by centrifugation for 15 min at 4000×g. The 
peptides were eluted from the membrane by centrifuga-
tion (3000×g, 15 min) with 500 μl of 15 % acetonitrile, 0.1 % 
trifluoroactic acid in water. The eluted peptides were dried 
using a speedvac to remove the organic solvents used for 
elution from the MWCO membranes. The sample was dis-
solved in 500 μl of 0.5 % trifluoroacetic acid and desalted 
with a C18-SD extraction disc cartridge (Sigma, USA). 
The eluted peptides were dried and reconstituted in 40 μl 
of 0.1  % formic acid in water. An estimation of peptide 
quantity was made using a Nano-drop spectrophotometer 
(Thermo Scientific Nanodrop 2000) at 205 nm absorbance 
where 1.0 absorbance unit corresponded to a peptide con-
centration of ~1 μg/μl.
2D‑HPLC–MS/MS data acquisition and peptide 
identification
The processed trypsin digested peptides were separated 
using two-dimensional liquid chromatographic method 
[18]. C-18 cleaned peptides obtained after modified FASP 
procedure were gradient fractionated on a C18 X-Terra 
column, (1  ×  100  mm, 3  µm, 100  Å, Waters, Milford, 
MA). Both eluents A (water) and B (90  % acetonitrile) 
contained 20  mM ammonium formate buffer pH 10.0. 
A total of 30 fractions were collected using a gradient of 
1–44 % of solvent B in 30 min, at a flow rate of 300 µl/
min. The resulting fractions were concatenated to eight 
fractions, dried and dissolved in 50 µl of eluent A (0.1 % 
Formic Acid). One microgram from each concatenated 
fraction was injected into a splitless nano-flow Tempo 
LC system (Eksigent, Dublin, CA) via a PepMap100 trap 
column (0.3 ×  5  mm, 5  µm, 100  Å, Dionex, Sunnyvale, 
CA) and a 100 μm × 150 mm analytical column packed 
with 3  μm Luna C18(2) (Phenomenex, Torrance, CA). 
Both eluents A (2  % acetonitrile in water) and B (98  % 
acetonitrile) contained 0.1  % formic acid as ion-pairing 
modifier. A 0.44 % acetonitrile per minute linear gradient 
(0–35 % B in 80 min, 500 nl/min) was used for peptide 
elution, followed by 5 min wash with 80 % B.
Samples were analyzed on a 5600 TripleTOF mass 
spectrometer (SCIEX, Canada) in standard MS/MS data 
dependent acquisition (DDA) mode also referred as 
information dependent acquisition (IDA). Each DDA/
IDA cycle included a 250  ms MS scan (400–1600 m/z) 
and up to 20 MS/MS (100  ms each, 100–1600  m/z) for 
ions state of +2 to +5 and an intensity of minimum 
300  cps. Selected ions and their isotopes were dynami-
cally excluded from further fragmentation for 12 s.
For each pooled sample the resulting eight instrument-
level WIFF files were converted to MGF format using the 
conversion tool bundled with Analyst. These were then 
sequentially concatenated into a single MGF file for each 
sample pool. Peptide identification and quantitation was 
done using X!tandem (cyclone 2012.10.01.1) [19]. Pep-
tides were identified against a human database of the 
June 2015 release of SwissProt with the following search 
settings: constant modification C +57.021 (cysteine pro-
tection); variable modifications: M, W +15.995 (oxida-
tion) or +31.989 (double oxidation); S, T, Y +79.966 
(phosphorylation), N, Q +0.984 (deamidation); parent 
mass error: ±20 PPM, fragment mass error: 0.1 Da. Pep-
tide identification Log10 expectation values were com-
puted using a survival function approach [20, 21].
SWATH‑MS acquisition
SWATH-MS, also referred to as data independent acquisi-
tion (DIA), runs were conducted using a 5600 TripleTOF 
mass-spectrometer, which operated in a looped product 
ion mode. This mode helps instrument to allow quadru-
pole resolution of 25 amu per mass selection. Precursor 
selection windows had an overlap of 1 Da with their adja-
cent selection window to ensure complete isotope coverage 
between SWATH blocks. Each cycle of SWATH analysis 
consisted of a 100 ms MS scan and a 100 ms MS/MS scan 
in 25 m/z blocks in 400–1250 m/z range, and a total of 34 
SWATH blocks were collected for each scan. An accumula-
tion time of 100 ms was used for each fragment ion scan 
and for the survey scans acquired at the beginning of each 
cycle, resulting in a total cycle time of 3.5 s. The collision 
energy for each window was determined on the basis of 
the collision energy for a 2+ ion centered in the respec-
tive window (equation: 0.0625 × m/z −3.5) with a collision 
energy spread of 15 eV. The mass spectrometer was always 
operated in high sensitivity mode. Peptides were separated 
using the same LC system configuration as for the sec-
ond dimension DDA/IDA acquisition, using a 0.30 % ace-
tonitrile per minute linear gradient (0–33 % B in 110 min, 
500 nl/min), followed by a 5 min wash with 80 % B.
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SWATH library and analysis
For SWATH library construction all non-modified pep-
tides across a large dataset 2D DDA/IDA runs were con-
catenated into a non-redundant collection using methods 
described earlier [22]. We opted to include all peptides 
from a broader study of eight urine pool samples, regard-
less of their expectation values or number of peptides per 
protein detected in each run, to yield maximum SWATH 
depth. The peptide entries from each DDA/IDA run were 
retention-aligned against a system average value using 
the retention times extracted for the custom peptides 
spiked into each sample.
To enhance our potential SWATH extraction cover-
age, we developed a method to supplement this library 
with transitions from the comprehensive human SWATH 
library [23]. These “10K-library” transitions represented 
peptide fragment ion patterns detected in SWATH runs, 
which differ somewhat from their DDA/IDA counter-
parts due to differences in instrument fragmentation set-
tings across the acquisition methods. This library also 
provided transition versions for multiple potential charge 
states of a given peptide, a feature that varies between 1D 
and 2D runs as a product of finite instrument acquisition 
time per MS/MS cycle.
This combined library was retention aligned against 
average retention values acquired from prior DDA/
IDA runs under identical chromatographic settings. 
This library drove the SWATH analysis component of 
Peakview (1.2.0.4; AB Sciex 2012). The SWATH param-
eters were a 6 min extraction window (±3 min), a mass 
accuracy 50 PPM, a search depth of 100 peptides per 
protein, 6 transitions per peptide, and a 1 % false discov-
ery rate. Extraction was performed on all eight SWATH 
runs of our larger study simultaneously to permit optimal 
“gap filling”, yielding a modest transition detection rate of 
~11 % (21,205 of 193,112 targeted transitions) spanning 
6050 peptides.
The utility of the custom-peptide [24] based retention 
alignments is illustrated in (Additional file  1: Table  S1). 
The differences between the library target retention 
times and their actual extracted retention times in both 
of our SWATH runs are well within our SWATH reten-
tion extraction time window with no apparent system-
atic skewing of the retention differences, indicating good 
control over the chromatography across the SWATH 
runs and between the methods.
Results and discussion
Optimization of urine sample preparation for mass 
spectrometry
The aim of the present study was to develop methods for 
the reliable comparison of the urinary proteome during 
CPB. Preliminary studies indicated that urine samples 
collected during cardiac surgery contained substance(s) 
that interfered with processing and chromatographic 
separations of the peptides derived from these samples. 
However, samples collected post operatively from the 
same patient group did not appear to contain the chro-
matographic-interfering substances. Although unproven 
it was felt that the most likely cause of these interfering 
effects were due to lipophilic substances possibly propo-
fol, an anaesthetic used during the surgery.
After examining several approaches we established that 
a modified version of the filter-aided sample preparation 
(FASP) procedure [17] provided a suitable approach. This 
procedure involves sample processing with subsequent 
concentration of the sample using a molecular weight 
cut off filter. The concentrated sample is then processed 
in  situ and the resulting peptides are eluted for analy-
sis. This approach allows for sample concentration and 
clean-up in a single reaction vessel, limiting protein loss 
and minimizing technical variability. The SDS and urea 
used in this procedure also offered a means of removing 
hydrophobic interfering substances which were present 
in the samples collected from patients during surgery. 
Preliminary experiments determined that samples pre-
pared with either 3 or 10 kDa cut off filters proposed in 
the original FASP method [17] still contained compounds 
that altered the chromatographic properties of the recov-
ered peptides (Fig.  1a). The retention times of peptides 
isolated under these conditions were reduced and there 
was considerable peak spreading which resulted in sub-
optimal separations. Increasing the pore size of the filters 
to 30  kDa molecular weight cut off membrane elimi-
nated this effect suggesting that the interfering materials 
were removed under these conditions (Fig. 1a). However, 
there was concern that the increased pore size could also 
result in the selective loss of lower molecular weight spe-
cies in the urine samples. A comparative analysis of the 
30  kDa membrane processed samples with those pro-
duced with 3 or 10  kDa membranes indicated that the 
30 kDa sample provided a greater number of proteins in 
the 1–30 kDa range and overall more protein identifica-
tions than the other samples (Fig. 1b). While these results 
could not exclude the possibility of some protein loss 
using the 30 kDa molecular weight cut off membranes, it 
was apparent that the recovery and range of proteins was 
better with these membranes than with either the 3 or 
10 kDa membranes. This increased recovery was demon-
strated by the higher numbers of protein identifications 
and the numbers of proteins with molecular weights 
less than 30 kDa in samples processed using the 30 kDa 
MWCO filters (502 and 162, respectively) as compared 
with the 3  kDa (290 and 97) or 10  kDa (394 and 123) 
MWCO processed samples. The recent results of Berger 
et al. suggest that perhaps even larger pore PVDF based 
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membranes may be used for sample preparation because 
of the efficiency of protein capture [25].
Differential protein analysis
Digests of the samples were analyzed by 2D-LC–MS and 
peptides were quantified by summing the intensities of all 
fragments in their associated CID spectra. Assignment 
of peptides into their source proteins was performed by 
X!tandem’s algorithm, and we chose to use its primary 
protein assignments only. Protein level intensities were 
the sum of the intensities of member peptides, expressed 
a log2 scale for simple differential analysis.
High confidence protein identifications were based on 
detection of at least two distinct peptides each with log10 
expectation scores of −1.5 or lower, roughly equivalent to 
a protein-level log10 expectation score of −3.0 or lower. 
This yielded the identification of 1154 proteins at the 
start of CPB and 915 proteins at 1-h into CPB surgery. 
The total number of unique proteins observed was 1325, 
with 744 proteins identified in both samples (Additional 
file 2: Table S2). However, over a third of the population 
of the proteins identified (581) were seen exclusively at 
either the start of CPB or 1-h into CPB, rendering them 
ambiguous for quantitative analysis. This result highlights 
Fig. 1 a The chromatographic properties of CPB urine samples processed using 3, 10 or 30 kDa MWCO filters in the modified-FASP method. The 
total ion chromatogram of each sample is given. Note the peak spreading and altered retention times in the 3 and 10 kDa MWCO membrane 
processed samples. b The predicted molecular weight and pI distribution of proteins identified from the same urine sample FASP processed with 3, 
10 or 30 kDa molecular weight cut-off membranes. The values beside each panel indicate the number of proteins with molecular weights less than 
30 kDa and the total number of proteins identified in sample
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the challenge of comparative analysis of complex samples 
by mass spectrometry which arises as a result of the sto-
chastic nature of instrument dependent data acquisition. 
Given the significant amount of time and effort commit-
ted to performing 2D DDA/IDA analysis and the vari-
able complementarity of coverage between samples this 
was felt to be a suboptimal approach because such out-
comes make it unclear if “missing” proteins in a sample 
were exclusively expressed in one set of the samples or if 
the peptides were simply not selected in one of the analy-
ses. This motivated us to examine the feasibility of using 
a hyper reaction monitoring data independent approach 
[15].
As described in the Methods and Materials, we gen-
erated a large SWATH library by combining an exist-
ing human protein transition library [23] (henceforth 
called the “10K-library”) and the results of our larger-
scale multiple 2D-LC–MS analysis of urines from car-
diac bypass patients. Our approach was to replace our 
observed DDA/IDA transitions with their 10  K-library 
counterparts for the peptides common to both library 
modes (and across their multiple charge state versions), 
and retain transition patterns for peptides observed 
in our samples’ library but outside the 10K-library. The 
10K-library’s unitless iRT retention scale [26] was lin-
early mapped into retention time using a simple regres-
sion, exhibiting an excellent correlation of R2 > 0.99. The 
combined library contained 18,628 peptides spanning 
3620 proteins; of these 3429 peptides spanning 934 pro-
teins were not part of the original 10K-library but were 
detected in our 2D analysis of urine samples (Additional 
file 3: Table S3).
SWATH analysis
We applied the same two-peptide rule for SWATH quan-
titation as we did for the 2D DDA/IDA analysis, giving 
4755 peptides spanning 730 proteins. This result sug-
gested a remaining 1295 proteins were potentially quan-
tifiable in SWATH, but by only a single peptide each. 
However, as quantitation based on a single peptide is less 
reliable these peptides were excluded from subsequent 
analysis. The complete peptide extraction report is avail-
able for additional exploration  (see  Availability of data 
and materials).
A total of 730 SWATH-quantifiable proteins were 
identified in the two sample pools, 552 of these also had 
quantitation values in both of the 2D LC runs. In addition 
there were 131 proteins that could be quantified using 
SWATH but not using the DDA/IDA derived data. These 
“gap filling” readouts indicated that SWATH presented 
the potential to differentially access approximately 22  % 
of the proteins that the 2D IDA dataset saw as incomplete 
(Additional file 3: Table S3).
Combined DDA/IDA and SWATH quantitation approaches
The combined DDA/IDA and SWATH quantitation data 
were used to complement the quantitative analysis of 
each approach. The correlation between log2 SWATH 
and DDA/IDA protein expression values within a time 
point was moderate (R2 = 0.794 for start of CPB across 
651 common proteins; R2  =  0.736 for 1-h into CPB 
across 584 common proteins), suggesting a general 
agreement between the readout technologies (Additional 
file 4: Table S4).
Applying a population filtering to these “acquisition 
technology-replicates” improved our quantitation reli-
ability with a modest loss of total quantified proteins. 
By expressing the difference between the SWATH and 
DDA/IDA readouts (at the same time point) as normal-
ized Z-scores, then discarding proteins with |Z|  >  1.65 
in either population, the resulting 475 common proteins 
(86 % of the 552 protein initial list) improved the cross-
technology difference correlation to R2  =  0.549, while 
the correlation of difference values for the 77 proteins 
rejected by this filtering step is low (R2 = 0.01) (Fig. 2).
These results were encouraging considering that 
SWATH runs consumed approximately one-sixth of the 
instrument acquisition time, with one-third amount less 
sample preparation time as their 2D-DDA/IDA counter-
parts and fewer steps to potentially compromise quan-
titation. Going forward, the SWATH ion library will be 
applied to broader AKI studies for the analysis of individ-
ual patient urine samples, where the subsequent “large-
N” readout sets are amendable to more sophisticated 
statistical methods.
The supportive filtered population of 475 proteins 
formed the basis of our biological interpretation. In the 
absence of sampling statistics, we chose a fairly severe 
cut-off of threefold (log2 1.59) protein expression differ-
ence required in both DDA/IDA and SWATH readouts. 
This gave 22 up-regulating proteins and 26 down-reg-
ulating proteins 1-h into CPB versus the start of CPB 
(Table 2).
Comparative analysis of the urinary proteome in patients 
undergoing CPB
The proteomic changes observed in these cardiac surgery 
patients were felt to reflect physiological responses to the 
trauma of the surgery and the associated bypass process, 
including ischemia reperfusion injury.
The majority of proteins that displayed altered expres-
sion after 1-h of CPB were localised to exosomes 
(Table  3). These findings are consistent with the obser-
vation that exosomes are derived from multivesicu-
lar bodies which fuse with renal tubular epithelial cell 
membranes before being secreted into the urine [27]. 
Urinary exosomes are typically isolated by differential 
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centrifugation prior to proteomic analysis, and identi-
fication of exosomal proteins here suggests that these 
methods may identify low abundance proteins; although 
proteome overlap between whole urine and exosomes 
has been reported [28]. These results could suggest that 
the repertoire of exosomal proteins changed during CPB 
but the process of exosome generation continued.
The up-regulated proteins were enriched for humoral 
immune responses (Table  4), which included predomi-
nantly innate features as outlined by the list of proteins 
involved (e.g. complement, lactotransferrin, myelop-
eroxisae and cathelicidin anti-microbial peptide). It is 
noteworthy that Chitinase-3-like protein 1 (CHI3L1, also 
called YKL-40) was also increased at 1-h post initiation 
Fig. 2 The use of protein level intensity correlations between 2D DDA/IDA and SWATH runs to improve quantitation reliability. Comparison of log2 
protein intensities a START of CPB b 1-hour CPB. c The expression of differences between SWATH and DDA/IDA readouts (at the same time point) 
as normalized Z-scores identifies proteins that show discordance between the two methods. This provides a basis for discarding the proteins with 
|Z| > 1.65 in either population (as shown by the red dots), the resulting 475 common proteins (86 % of the 552 protein initial list; the blue dots). This 
improved the cross-technology difference correlation to R2 = 0.549. d The correlation of difference values for the 77 proteins rejected by this filter-
ing step, shown is very low (R2 = 0.01)
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Table 2 Correlation filtered 2D DDA/IDA and  SWATH protein differences of  magnitude greater than  1.59 (threefold 








2.53 3.09 P01023 Alpha-2-macroglobulin
1.78 3.53 P04083 Annexin A1
2.05 3.04 P04003 C4b-binding protein alpha chain
3.53 5.73 P00915 Carbonic anhydrase 1
1.82 4.47 P49913 Cathelicidin antimicrobial peptide
1.87 2.36 P36222 Chitinase-3-like protein 1
3.47 4.00 P08123 Collagen alpha-2(I) chain
1.84 2.82 P09871 Complement C1 s subcomponent
1.86 2.01 P02671 Fibrinogen alpha chain
2.37 2.03 P02675 Fibrinogen beta chain
1.76 4.09 P30043 Flavin reductase (NADPH)
1.64 1.84 P00738 Haptoglobin
2.1 1.79 P01860 Ig gamma-3 chain C region
2.09 1.99 P13645 Keratin, type I cytoskeletal 10
2.3 4.12 P02533 Keratin, type I cytoskeletal 14
3.48 6.95 P08779 Keratin, type I cytoskeletal 16
5.44 5.87 Q04695 Keratin, type I cytoskeletal 17
2.17 4.22 P13647 Keratin, type II cytoskeletal 5
2.09 2.79 P02788 Lactotransferrin
3.18 5.10 P14780 Matrix metalloproteinase-9
2.22 2.94 P05164 Myeloperoxidase
2.48 3.59 P05109 Protein S100-A8
(B)
−1.82 −1.94 P02763 Alpha-1-acid glycoprotein 1
−2.35 −2.10 P05090 Apolipoprotein D
−2.14 −3.50 P55287 Cadherin-11
−2.23 −2.87 P19022 Cadherin-2
−1.64 −1.80 P49747 Cartilage oligomeric matrix protein
−2.39 −2.86 P39059 Collagen alpha-1(XV) chain
−1.66 −2.32 P08174 Complement decay-accelerating factor
−1.64 −2.43 Q9HCU0 Endosialin
−1.92 −2.97 P17900 Ganglioside GM2 activator
−3.02 −2.24 Q96RW7 Hemicentin-1
−2.31 −2.30 O75144 ICOS ligand
−2.31 −2.63 Q9BRK3 Matrix-remodeling-associated protein 8
−1.72 −2.20 P08571 Monocyte differentiation antigen CD14
−1.78 −1.62 Q9BXP8 Pappalysin-2
−2.63 −1.72 P0DJD8 Pepsin A-3
−2.16 −1.72 Q6UXB8 Peptidase inhibitor 16
−1.7 −2.24 Q9HCN6 Platelet glycoprotein VI
−1.92 −1.60 P07602 Prosaposin
−1.88 −2.83 Q8WZ75 Roundabout homolog 4
−1.79 −2.70 O00241 Signal-regulatory protein beta-1
−2.02 −3.47 P19320 Vascular cell adhesion protein 1
−2.16 −2.73 Q6EMK4 Vasorin
−1.79 −2.34 Q12907 Vesicular integral-membrane protein VIP36
Page 9 of 12Dwivedi et al. Clin Proteom  (2016) 13:17 
of CPB. CHI3L1 is a member of the chilectin subfam-
ily of the 18 glycosyl hydrolase family. This protein has 
retained the ability to bind heparin, collagen and chitin 
but it is enzymatically inactive [29]. It has been shown 
to have a number of immunostimulatory properties 
for the adaptive immune system as well as pro-inflam-
matory activities [29]. Increased levels of CHI3L1 have 
been associated with loss of renal function in diabetes, 
and renal or cardiac transplantation patients [30–33]. 
Our present observations suggest that CHI3L1 levels 
also increase in patients undergoing cardiac bypass sur-
gery potentially as a result of intra operative subclinical 
ischemia–reperfusion injury.
These up-regulated proteins also contained a number 
of extracellular components, although these proteins 
appeared to derive more from vesicle or granule con-
tents. ECM reorganization was a process characterized 
by the up-regulated proteins, including elevation of uri-
nary MMP9. These findings are consistent with reports 
that demonstrate elevated urinary MMP7 and renal 
MMP2 expression in ischemia reperfusion injury of renal 
allografts [4, 34]. While there was one diabetic patient in 
the cohort, it is unlikely that the acute intraoperative ele-
vation of urinary MMP9 observed over 1-h of CPB was 
related to undocumented diabetic nephropathy [35].
Significantly, the up-regulated proteins also reflected 
general activation/regulation of innate immunity (C4b, 
lactotransferrin, protein S100-A8, myeloperoxidase) 
which is consistent with rapid, generic responses to car-
diac surgery-induced tissue injury. Interestingly, there 
were also changes suggesting that the adaptive immune 
response might be down-regulated following 1-h on CPB, 
a process not previously described. Taken together, these 
findings corroborate pre-clinical models of the immune 
responses to renal ischemia reperfusion injury, but fur-
ther expand on them to demonstrate that repair and 
re-modeling processes may be initiated sooner than pre-
viously thought [36].
It should be emphasised that the criteria used for the 
selection of proteins with significant changes between 
the two time points was based on the requirement that 
the protein was identified in both SWATH and DDA/
IDA analyses of the same sample, and the changes had 
to be of comparable magnitudes. These represent very 
stringent criteria to provide confidence regarding the 
presence and magnitude of the change using two inde-
pendent analytical methods. This was not meant to imply 
that other quantitative changes predicted by observa-
tions made in only one of the approaches (DDA/IDA or 







−2.33 −2.58 Q96DA0 Zymogen granule protein 16 homolog B
These formed the basis for our biological analysis
Table 3 GO cellular components enriched in differentially regulated proteins
Only cellular components enriched with a p value of 10−5 or less are reported. Analysis was performed using String database [37]
Term Up regulated Down regulated
Genes p value Bonferroni Genes p value Bonferroni
Extracellular exosome 20 4.41 × 10−14 23 4.99 × 10−18
Extracellular membrane-bounded organelle 20 4.41 × 10−14 23 4.99 × 10−18
Extracellular organelle 20 4.79 × 10−14 23 5.50 × 10−18
Extracellular region part 21 9.89 × 10−14 22 3.22 × 10−13
Membrane-bounded vesicle 20 2.81 × 10−12 23 6.18 × 10−16
Extracellular region 21 3.59 × 10−12 22 1.33 × 10−11
Vesicle 20 5.11 × 10−12 23 1.24 × 10−15
Extracellular space 15 1.82 × 10−11 11 2.95 × 10−5
Blood microparticle 6 1.40 × 10−6 * *
Cytoplasmic membrane-bounded vesicle lumen 5 3.08 × 10−5 * *
Vesicle lumen 5 3.27E × 10−5 * *
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of such changes is lower and would require validation 
using alternate methodologies.
Conclusions
Our results provide a method for analyzing the urinary 
proteomic changes in adult patients undergoing cardiac 
surgery. Unlike the original FASP method the current pro-
cedure does not use SDS. The method requires limited 
sample processing to remove interfering substances and 
generates mass spectrometry ready samples. The design 
is such that it can be readily applied to large numbers of 
clinical samples with the potential for automation. The 
introduction of SWATH into the workflow offers several 
benefits to the analysis. The most significant aspect is the 
ability to consistently report on the same panel of >700 pro-
teins in each analysis. This allows for more confident com-
parisons between samples, while keeping both the sample 
quantity requirements and the mass spectrometer instru-
ment time relatively low. Although SWATH does not cur-
rently offer the analytical depth provided by 2D-LC–MS/
MS analyses, it may be possible to extend the level of quan-
titation through longer chromatographic run times or via 
pre-fractionation steps prior to SWATH-MS. There have 
been several comparisons to suggest that SWATH provides 
comparable quantitative analysis to other methods [22]. 
The approach outlined here is particularly relevant to the 
analysis of sequential urines from patients in various clini-
cal conditions, including intraoperative samples.
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